Recruiting

KarXTA Study to Evaluate the Effect of KarXT on Urological Safety

Sponsor:

Bristol-Myers Squibb

Code:

NCT07221877

Conditions

Schizophrenia

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Xanomeline/trospium chloride

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-02. This information was provided to ClinicalTrials.gov by Bristol-Myers Squibb on 2026-06-03.